In vitro studies of induction and inhibition of drug oxidation in man
- 31 December 1987
- journal article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 33 (1), 101-108
- https://doi.org/10.1016/0163-7258(87)90036-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Phenacetin O‐deethylase: an activity of a cytochrome P‐450 showing genetic linkage with that catalysing the 4‐hydroxylation of debrisoquine?British Journal of Clinical Pharmacology, 1985
- Genetic polymorphism in drug oxidation: In vitro studies of human debrisoquine 4-hydroxylase and bufuralol 1′-hydroxylase activitiesBiochemical Pharmacology, 1985
- Human cytochromes P-450Xenobiotica, 1984
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- Assay and characterisation of debrisoquine 4‐hydroxylase activity of microsomal fractions of human liver.British Journal of Clinical Pharmacology, 1982
- The genetic controlof bufuralol metabolisminmanEuropean Journal of Drug Metabolism and Pharmacokinetics, 1982
- Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymesXenobiotica, 1982
- Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractionsBiochemical Pharmacology, 1981
- Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.British Journal of Clinical Pharmacology, 1981
- Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.British Journal of Clinical Pharmacology, 1980